Dr. Muffazal Lakdawala

Dr. Muffazal Lakdawala is a highly experienced General Surgeon with 35 years of dedicated practice. He holds an MBBS and an MS in General Surgery, demonstrating a strong foundation in surgical principles and patient care. Dr. Lakdawala's expertise has been recognized in prominent media, including a Reuters report detailing the introduction of Mounjaro by Eli Lilly in India. This report underscored a critical healthcare trend: the escalating demand for effective weight-loss interventions throughout the region. Dr. Lakdawala's participation in such discussions highlights his engagement with advancements in bariatric and metabolic surgery, contributing expert perspectives to the evolving landscape of obesity management. His involvement in widely syndicated media coverage signifies his role as a thought leader in his field, contributing to public awareness and understanding of contemporary medical solutions. Dr. Lakdawala is committed to evidence-based practice and the application of innovative treatments to address complex surgical conditions, particularly those related to metabolic health and weight management. His extensive experience and recognized contributions position him as a leading figure in General Surgery.